Cocreation of a conversational agent to help patients adhere to their varenicline treatment: A study protocol.

ABSTRACT:

Objective

Varenicline is the most efficacious approved smoking cessation medication, making it one of the most cost-effective clinical interventions for reducing tobacco-related morbidity and mortality. Adhering to varenicline is strongly associated with smoking cessation. Healthbots have the potential to help people adhere to their medications by scaling up evidence-based behavioral interventions. In this protocol, we outline how we will follow the UK's Medical Research Council's guidance to codesign a theory-informed, evidence-based, and patient-centered healthbot to help people adhere to varenicline.

Methods

The study will utilize the Discover, Design and Build, and Test framework and will include three phases: (a) a rapid review and interviews with 20 patients and 20 hea

SUBMITTER: Minian N 

PROVIDER: S-EPMC10291536 | biostudies-literature | 2023 Jan-Dec

REPOSITORIES: biostudies-literature